Yoga program for lung cancer patients and their caregivers
Official title: Dyadic yoga Program for Patients with Lung Cancer Undergoing Radiotherapy and their Family Caregivers
Funded at University of Tx Md Anderson Can Ctr · NIH-10818157 · Data updated 2026-11-12
This study is looking at how a special yoga program can help lung cancer patients and their family caregivers feel better during treatment by improving their physical health and emotional well-being.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | August 1, 2024 |
| Project end | July 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $365,817 |
| NIH project number | 4R37CA231522-07 |
| Project ID | NIH-10818157 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates include lung cancer patients currently undergoing radiotherapy and their family caregivers.
✕Less likely to help
Patients who are not undergoing radiotherapy or do not have a family caregiver may not receive benefit from this research.
What this research studies
This research investigates a dyadic yoga program designed for lung cancer patients undergoing radiotherapy and their family caregivers. The program aims to improve both physical function and quality of life by addressing the physical and psychological challenges faced by patients and the emotional burden experienced by caregivers. Participants will engage in instructor-led yoga sessions that promote relaxation, physical activity, and emotional support, potentially enhancing their overall well-being during treatment. The study will assess the effectiveness of this intervention in improving outcomes for both patients and caregivers.
Why it matters
Potential benefit: If successful, this research could enhance the quality of life and physical function for lung cancer patients and reduce the emotional burden on their caregivers.
How similar studies have gone: Previous research has shown that similar dyadic interventions can improve outcomes for both patients and caregivers, indicating a promising approach.
Where this research is happening
-
University of Tx Md Anderson Can Ctr
Houston, United States Active
Researchers
- Principal investigator: Milbury, Kathrin — University of Tx Md Anderson Can Ctr
- Study coordinator: Milbury, Kathrin
Related research
Other NIH-funded projects on the same topics.
-
Safer lung cancer radiotherapy with smart AI helpers
A new AI-based method aims to precisely map tumors and nearby organs during lung cancer radiotherapy to reduce side effects and improve outcomes.
-
PET/CT scans and blood tests to guide immunotherapy, chemotherapy, and focused radiation for metastatic lung cancer
This project combines PET/CT imaging and blood immune tests to help identify which people with metastatic non‑small cell lung cancer will benefit from immunotherapy plus chemotherapy and targeted radiation.
-
Connecting lung cancer caregivers to supportive services and navigation
This project builds a practical system to identify what lung cancer caregivers need and link them to local support services and navigators.
-
Improving lung cancer radiation treatment with AI
This work aims to make radiation treatment for lung cancer safer and more effective by using new artificial intelligence tools.
-
Using AI to improve radiation therapy for lung cancer
This study is looking at how to use artificial intelligence to make better images for radiation therapy in patients with early-stage non-small cell lung cancer, so that doctors can more accurately target the treatment as the tumor changes, which could lead to better results for you.
-
Investigating how imaging and blood tests can predict responses to lung cancer treatments
This study is looking at how well patients with advanced lung cancer respond to a mix of chemotherapy and immunotherapy by using special imaging and blood tests, with the goal of personalizing treatments to help improve survival and reduce side effects.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.